Drugs that contain Acetaminophen; Ibuprofen Sodium
1. Combogesic Iv patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11446266 | HIKMA | Combination composition |
Oct, 2031
(7 years from now) | |
| US11896567 | HIKMA | Combination composition |
Oct, 2031
(7 years from now) | |
| US11389416 | HIKMA | Aqueous formulation comprising paracetamol and ibuprofen |
Jul, 2035
(11 years from now) | |
| US11213498 | HIKMA | Aqueous formulation comprising paracetamol and ibuprofen |
Jan, 2036
(11 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Oct 17, 2026 |
Market Authorisation Date: 17 October, 2023
Treatment: Method of treating moderate to severe pain in adults as an adjunct to opioid analgesics
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
COMBOGESIC IV family patents
